(Q51812873)

13 April 2018

title

Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00971-8

coronary balloon angioplasty

20 March 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556867

Cardiology and cardiovascular medicine

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00971-8

20 March 2024

author name string

Atul Aggarwal

1

1 reference

13 April 2018

David J. Schneider

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556867

20 March 2024

Burton E. Sobel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556867

20 March 2024

Harold L. Dauerman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556867

20 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

13 April 2018

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14556867

full work available at URL

20 March 2024

https://api.elsevier.com/content/article/PII:S0002914903009718?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00971-8

https://api.elsevier.com/content/article/PII:S0002914903009718?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00971-8

American Journal of Cardiology

20 March 2024

published in

1 reference

13 April 2018

volume

92

1 reference

13 April 2018

issue

8

1 reference

13 April 2018

page(s)

924-929

1 reference

13 April 2018

Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Morphological predictors of restenosis after coronary stenting in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Elevated Levels of Interleukin-6 in Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Plasma levels of C-reactive protein after coronary stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Unstable angina. A classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900971-8

7 January 2021

Identifiers

1 reference

13 April 2018

1 reference

13 April 2018